MAPT and Alzheimer disease: Analysis of phosphorylated tau protein and amyloid-β1-42 levels in cerebrospinal fluid (CSF) and an amyloid PET scan may be necessary to rule out AD as a major cause of CBS (Höglinger et al., 2017).